CVS

CVS

USD

CVS Health Corporation Common Stock

$78.080-0.360 (-0.459%)

Reaalajas hind

Healthcare
Healthcare Plans
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$78.440

Kõrge

$79.350

Madal

$77.560

Maht

4.28M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

99.1B

Tööstusharu

Healthcare Plans

Riik

United States

Kauplemisstatistika

Keskmine maht

7.31M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $43.56Praegune $78.080Kõrge $85.15

Seotud uudised

PR Newswire

CVS Health to hold Investor Day on December 9, 2025

CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide...

Vaata rohkem
CVS Health to hold Investor Day on December 9, 2025
Analyst Upgrades

TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100

TD Cowen analyst Charles Rhyee maintains CVS Health with a Buy and raises the price target from $99 to $100.

Vaata rohkem
TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100
Reuters

Obamacare premiums double, adding post Halloween fright for US health insurance shoppers

Americans shopping for 2026 Obamacare health insurance plans are facing a more than doubling of monthly premiums on average and are likely to postpone signing up in hopes of a last-minute reprieve, or walk away, health experts say.

Vaata rohkem
Obamacare premiums double, adding post Halloween fright for US health insurance shoppers
PR Newswire

CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity

CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is...

Vaata rohkem
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Analyst Upgrades

Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health with a Outperform and raises the price target from $85 to $95.

Vaata rohkem
Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95
Analyst Upgrades

RBC Capital Maintains Outperform on CVS Health, Raises Price Target to $93

RBC Capital analyst Ben Hendrix maintains CVS Health with a Outperform and raises the price target from $81 to $93.

Analyst Upgrades

Cantor Fitzgerald Maintains Overweight on CVS Health, Raises Price Target to $95

Cantor Fitzgerald analyst Sarah James maintains CVS Health with a Overweight and raises the price target from $78 to $95.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.